share_log

UnitedHealth | 8-K: Signing of Underwriting and Pricing Agreements

UnitedHealth | 8-K: Current report

联合健康 | 8-K：重大事件
SEC announcement ·  03/21 16:37
Moomoo AI 已提取核心信息
On March 19, 2024, UnitedHealth Group Incorporated, a healthcare and insurance giant, entered into agreements to sell a series of notes with varying interest rates and maturities, totaling $5.5 billion. The notes, ranging from 4.600% to 5.500% in interest rates and with maturity dates spanning from 2027 to 2064, were sold under an Underwriting Agreement and a Pricing Agreement with major financial institutions including BofA Securities, Barclays Capital, J.P. Morgan Securities, and Mizuho Securities USA. The sale was completed on March 21, 2024, with the issuance of the notes under an existing Indenture with U.S. Bank Trust Company as trustee. The transaction was registered under the Securities Act of 1933 and incorporated into UnitedHealth's automatic shelf registration statement. The company filed the necessary documents with the SEC, including the Underwriting and Pricing Agreements, Officers' Certificates, Company Orders, and legal opinion regarding the validity of the notes.
On March 19, 2024, UnitedHealth Group Incorporated, a healthcare and insurance giant, entered into agreements to sell a series of notes with varying interest rates and maturities, totaling $5.5 billion. The notes, ranging from 4.600% to 5.500% in interest rates and with maturity dates spanning from 2027 to 2064, were sold under an Underwriting Agreement and a Pricing Agreement with major financial institutions including BofA Securities, Barclays Capital, J.P. Morgan Securities, and Mizuho Securities USA. The sale was completed on March 21, 2024, with the issuance of the notes under an existing Indenture with U.S. Bank Trust Company as trustee. The transaction was registered under the Securities Act of 1933 and incorporated into UnitedHealth's automatic shelf registration statement. The company filed the necessary documents with the SEC, including the Underwriting and Pricing Agreements, Officers' Certificates, Company Orders, and legal opinion regarding the validity of the notes.
2024年3月19日，医疗保健和保险巨头UnitedHealth Group Incorporated达成协议，出售一系列利率和到期日各不相同的票据，总额为55亿美元。这些票据的利率从4.600％到5.500％不等，到期日为2027年至2064年，是根据承保协议和与美国美银证券、巴克莱资本、摩根大通证券和美国瑞穗证券等主要金融机构签订的定价协议出售的。此次出售于2024年3月21日完成，根据现有契约发行了票据，由美国银行信托公司担任受托人。该交易是根据1933年《证券法》注册的，并已纳入UnitedHealth的自动上架注册声明。该公司向美国证券交易委员会提交了必要的文件，包括承保和定价协议、高管证书、公司命令以及有关票据有效性的法律意见。
2024年3月19日，医疗保健和保险巨头UnitedHealth Group Incorporated达成协议，出售一系列利率和到期日各不相同的票据，总额为55亿美元。这些票据的利率从4.600％到5.500％不等，到期日为2027年至2064年，是根据承保协议和与美国美银证券、巴克莱资本、摩根大通证券和美国瑞穗证券等主要金融机构签订的定价协议出售的。此次出售于2024年3月21日完成，根据现有契约发行了票据，由美国银行信托公司担任受托人。该交易是根据1933年《证券法》注册的，并已纳入UnitedHealth的自动上架注册声明。该公司向美国证券交易委员会提交了必要的文件，包括承保和定价协议、高管证书、公司命令以及有关票据有效性的法律意见。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

独立文件7  查看翻译

独立文件8  查看翻译

独立文件9  查看翻译

独立文件10  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息